Pierre Étienne

3.3k total citations
57 papers, 2.0k citations indexed

About

Pierre Étienne is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Pierre Étienne has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 13 papers in Physiology. Recurrent topics in Pierre Étienne's work include Neuroscience and Neuropharmacology Research (10 papers), Neuropeptides and Animal Physiology (8 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Pierre Étienne is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neuropeptides and Animal Physiology (8 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Pierre Étienne collaborates with scholars based in Canada, United States and Switzerland. Pierre Étienne's co-authors include N.P.V. Nair, Paul L. Wood, Serge Gauthier, Samarthji Lal, John C.S. Breitner, Judes Poirier, Yves Robitaille, Pedro Rosa‐Neto, Rémi Quirion and Marie‐Élyse Lafaille‐Magnan and has published in prestigious journals such as Nature, American Journal of Psychiatry and Neurology.

In The Last Decade

Pierre Étienne

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Étienne Canada 25 795 570 516 410 357 57 2.0k
Philip D. Kanof United States 20 920 1.2× 853 1.5× 482 0.9× 666 1.6× 222 0.6× 37 2.3k
Yutaka Gomita Japan 27 1.3k 1.7× 775 1.4× 330 0.6× 238 0.6× 266 0.7× 236 2.7k
Peter J. Knott United States 25 1.1k 1.4× 609 1.1× 627 1.2× 387 0.9× 461 1.3× 51 2.7k
Garry Blessed United Kingdom 11 705 0.9× 626 1.1× 849 1.6× 678 1.7× 409 1.1× 15 2.0k
C. G. Gottfries Sweden 28 591 0.7× 407 0.7× 539 1.0× 476 1.2× 594 1.7× 68 2.1k
Robert Perry United Kingdom 14 434 0.5× 396 0.7× 388 0.8× 396 1.0× 436 1.2× 19 1.9k
Philip A. Berger United States 31 956 1.2× 565 1.0× 278 0.5× 452 1.1× 863 2.4× 93 3.0k
László G. Hársing Hungary 30 1.6k 2.1× 1.2k 2.1× 311 0.6× 224 0.5× 168 0.5× 138 2.7k
Ronald J. Polinsky United States 29 684 0.9× 831 1.5× 980 1.9× 397 1.0× 396 1.1× 75 3.2k
Pamela White United Kingdom 18 894 1.1× 808 1.4× 764 1.5× 760 1.9× 215 0.6× 37 2.6k

Countries citing papers authored by Pierre Étienne

Since Specialization
Citations

This map shows the geographic impact of Pierre Étienne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Étienne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Étienne more than expected).

Fields of papers citing papers by Pierre Étienne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Étienne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Étienne. The network helps show where Pierre Étienne may publish in the future.

Co-authorship network of co-authors of Pierre Étienne

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Étienne. A scholar is included among the top collaborators of Pierre Étienne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Étienne. Pierre Étienne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lonergan, Michelle, et al.. (2022). Treatment of adjustment disorder stemming from romantic betrayal using memory reactivation under propranolol: A open-label interrupted time series trial. Journal of Affective Disorders. 317. 98–106. 2 indexed citations
2.
Meyer, Pierre‐François, Jennifer Tremblay‐Mercier, Jeannie‐Marie Leoutsakos, et al.. (2019). INTREPAD. Neurology. 92(18). e2070–e2080. 80 indexed citations
3.
Lafaille‐Magnan, Marie‐Élyse, Judes Poirier, Pierre Étienne, et al.. (2017). Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology. 89(4). 327–335. 104 indexed citations
4.
Breitner, John C.S., Judes Poirier, Pierre Étienne, & Jeannie‐Marie Leoutsakos. (2016). RATIONALE AND STRUCTURE FOR A NEW CENTER FOR STUDIES ON PREVENTION OF ALZHEIMER’S DISEASE (STOP-AD). The Journal of Prevention of Alzheimer s Disease. 3(4). 1–7. 42 indexed citations
5.
Tucholka, Alan, et al.. (2015). Emotional face processing in post-traumatic stress disorder after reconsolidation impairment using propranolol: A pilot fMRI study. Journal of Anxiety Disorders. 36. 127–133. 29 indexed citations
6.
Fischman, A., et al.. (1996). Sustained 5HT2A receptor occupancy of ziprasidone using pet ligand 18F setoperone in healthy volunteers. European Neuropsychopharmacology. 6. 177–177. 2 indexed citations
7.
Ko, Grant N., et al.. (1995). Status report: Ziprasidone. Schizophrenia Research. 15(1-2). 154–154. 6 indexed citations
8.
Abbott, Frances V., Pierre Étienne, Keith B.J. Franklin, et al.. (1992). Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology. 108(1-2). 60–66. 88 indexed citations
9.
10.
Chouinard, Guy, et al.. (1990). A pilot study of magnesium aspartate hydrochloride (Magnesiocard®) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(2). 171–180. 43 indexed citations
11.
Mondadori, Cesare & Pierre Étienne. (1990). Nootropic effects of ACE inhibitors in mice. Psychopharmacology. 100(3). 301–307. 48 indexed citations
12.
Boast, Carl A., Susan Gerhardt, Gary Pastor, et al.. (1988). The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Research. 442(2). 345–348. 214 indexed citations
13.
Sinton, Christopher M., John R. McCullough, Risto J. Ilmoniemi, & Pierre Étienne. (1986). Modulation of Auditory Evoked Magnetic Fields by Benzodiazepines. Neuropsychobiology. 16(4). 215–218. 2 indexed citations
14.
Moroni, Flavio, Giovanni Lombardi, Yves Robitaille, & Pierre Étienne. (1986). Senile Dementia and Alzheimer's disease: Lack of changes of the cortical content of Quinolinic Acid. Neurobiology of Aging. 7(4). 249–253. 26 indexed citations
15.
Nair, N.P.V., Samarthji Lal, Joseph Thavundayil, et al.. (1984). CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man. Neuropeptides. 4(4). 281–291. 14 indexed citations
16.
Wood, Paul L., Pierre Étienne, Samarthji Lal, et al.. (1983). A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. Journal of the Neurological Sciences. 62(1-3). 211–217. 63 indexed citations
17.
Étienne, Pierre, et al.. (1981). Alzheimer disease. Neurology. 31(12). 1552–1552. 50 indexed citations
18.
Étienne, Pierre, et al.. (1981). Adverse effects of medical and psychiatric workup in six demented geriatric patients. American Journal of Psychiatry. 138(4). 520–521. 9 indexed citations
19.
Young, Simon N., Pierre Étienne, & Theodore L. Sourkes. (1976). Relationship between rat brain and cisternal CSF tryptophan concentrations.. Journal of Neurology Neurosurgery & Psychiatry. 39(3). 239–243. 27 indexed citations
20.
Étienne, Pierre. (1968). Les Baoulé et le temps. 5(3). 17–37.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip D. Kanof Breakdown of academic impact, for papers by Yutaka Gomita Breakdown of academic impact, for papers by Peter J. Knott Breakdown of academic impact, for papers by Garry Blessed Breakdown of academic impact, for papers by C. G. Gottfries Breakdown of academic impact, for papers by Robert Perry Breakdown of academic impact, for papers by Philip A. Berger Breakdown of academic impact, for papers by László G. Hársing Breakdown of academic impact, for papers by Ronald J. Polinsky Breakdown of academic impact, for papers by Pamela White
Rankless by CCL
2026